Dr. Jennifer Lynne Bath has served as the president and chief executive officer of ImmunoPreciseAntibodies (IPA), an AI-driven biotherapeutics company located in Austin, Texas, since 2018. Her responsibilities in this position involve complete oversight of corporate transformation and strategy. Dr. Jennifer Lynne Bath also directs acquisitions and integrations for numerous international subsidiaries.
Jennifer Bath
AI Biotherapeutics Leader